MET and Miyoshi myopathy: SL1 (1–4 μM) was capable of selectively bind to c-MET+ MM cells but not to normal B cells thus suppressing growth, adhesion, migration, and downstream c-MET signaling (pERK, pAKT) of MM cells in a co-culture model with the HS5 cell line.